A Blend of AI-Enabled and Revenue-Generating HealthTech Companies
Our Strategy
Focused Healthcare Investment
10 – 15
target companies
Series A
+
investment stage
Global
mandate with US focus
~
4 years
average holding period
INVESTMENT CRITERIA
What We Look For
Atlas focuses on companies that meet a clear set of investment criteria:
- Global mandate with a US focus
- US$1 to 5m+ in revenue
- Proven assets with momentum in their home market
- Potential to scale into new healthcare markets
- Established management teams with successful track records
KEY SECTORS
Where We Invest
Software
AI-enabled healthcare software
MedTech
Medical technology and medical devices
Services
Healthcare services
Biotech
life sciences and biotechnology
GEOGRAPHY
Global Mandate. US Focus. Strategic Market Expansion.
The platform supports companies with proven momentum in their home markets and the potential to scale into strategic healthcare markets, including UAE and the wider GCC. For US HealthTech companies expanding to the GCC, Atlas provides the regulatory access, local partnerships and healthcare market entry support that turn a global mandate into commercial presence on the ground.
